lorazepam has been researched along with oxcarbazepine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Michelon, P; Ojemann, JG; Vettel, JM; Zacks, JM | 1 |
| Hug, BL | 1 |
| Comes, M; Cruz, N; de Arce, R; Fernández-Villamor, R; García-Campayo, J; Manuel Crespo, J; Manuel Olivares, J; Moríñigo, A; Pérez-Blanco, J; Roca, E; Vallès, V; Vieta, E | 1 |
| Akiyama, T; Otsubo, H | 1 |
| Dempsey, M | 1 |
2 review(s) available for lorazepam and oxcarbazepine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Antiepileptic drugs in North America].
Topics: Anticonvulsants; Carbamazepine; Drug Approval; Fructose; Humans; Japan; Lamotrigine; Levetiracetam; Lorazepam; North America; Phenytoin; Piracetam; Topiramate; Triazines | 2010 |
1 trial(s) available for lorazepam and oxcarbazepine
| Article | Year |
|---|---|
A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combination; Female; GABA Modulators; Humans; Impulsive Behavior; Lithium Chloride; Long-Term Care; Lorazepam; Male; Oxcarbazepine; Pilot Projects; Psychiatric Status Rating Scales; Reproducibility of Results; Sample Size; Secondary Prevention; Survival Analysis | 2008 |
4 other study(ies) available for lorazepam and oxcarbazepine
| Article | Year |
|---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Functional reorganization of spatial transformations after a parietal lesion.
Topics: Adult; Anticonvulsants; Brain Mapping; Carbamazepine; Combined Modality Therapy; Drug Therapy, Combination; Epilepsy, Complex Partial; Female; Functional Laterality; Head Injuries, Closed; Humans; Imagination; Lamotrigine; Lorazepam; Magnetic Resonance Imaging; Male; Neuronal Plasticity; Oxcarbazepine; Parietal Lobe; Psychomotor Performance; Rotation; Space Perception; Surveys and Questionnaires; Triazines | 2004 |
[Somnolence of unknown origin--illness or drug problem?].
Topics: Anticonvulsants; Carbamazepine; Diagnosis, Differential; Disorders of Excessive Somnolence; Drug Interactions; Drug Therapy, Combination; Epilepsy, Temporal Lobe; Female; Humans; Lamotrigine; Lorazepam; Middle Aged; Oxcarbazepine; Psychotic Disorders; Triazines | 2006 |
A true mystery diagnosis.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Central Nervous System Stimulants; Confusion; Diagnosis, Differential; Disorders of Excessive Somnolence; Humans; Hyperphagia; Hypnotics and Sedatives; Kleine-Levin Syndrome; Lorazepam; Male; Methylphenidate; Oxcarbazepine | 2011 |